Lecanemab-Irmb Suppliers & Bulk Manufacturers
Available Forms: Injection
Available Strengths: 100 mg/mL
Reference Brands: Leqembi (USA/EU)
Category: Neurology
Lecanemab-irmb is a humanized monoclonal antibody used for early Alzheimer’s disease. It targets and clears amyloid-beta protofibrils to help slow cognitive and functional decline. The treatment is administered under medical supervision as part of a disease-modifying therapy program for patients with mild cognitive impairment or mild dementia due to Alzheimer’s. Lecanemab-irmb is available in Injection and strengths such as 100 mg/mL. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Lecanemab-irmb is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.
| Technical Specifications & Supply Details | |
|---|---|
| Lead Time | 7 to 60 days (depending on batch size & schedule) |
| MOQ | As per manufacturer’s batch size |
| COA | Available with every batch |
| Regulatory Dossier / DMF | Available upon request |
| Export Documentation | FSC, COA, Manufacturing License, Product Permission |
| Standards | IP, BP, USP |
| Certifications | WHO-GMP, EU-GMP, USFDA (as applicable) |
Lecanemab-irmb can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Lecanemab-irmb is used for treating early Alzheimer’s disease, specifically in patients with mild cognitive impairment or mild dementia who have confirmed amyloid-beta buildup in the brain.
It is a humanized IgG1 monoclonal antibody developed to target aggregated forms of amyloid-beta (Aβ) in the brain.
The trade name is Leqembi.
It is developed and marketed by Eisai in partnership with Biogen.
The generic name is Lecanemab-irmb.
The brand name is Leqembi.
It is manufactured by Eisai facilities under global production and quality standards.
Related Products
Donepezil Hydrochloride
Strength:
5 mg, 10 mg, 23 mg
Form: Tablets
Reference Brands: Aricept (USA/EU)
View Details
Acetazolamide Sodium
Strength:
125 mg, 250 mg, 500 mg,
Form: Tablets/ capsules/ Injectable
Reference Brands: Diamox (USA)
View Details
Rimegepant
Strength:
75 mg
Form: Tablets
Reference Brands: Nurtec ODT (USA), Vydura (EU)
View Details
Pimavanserin
Strength:
17 mg, 34 mg, 51 mg
Form: Tablets
Reference Brands: Nuplazid (USA)
View DetailsQuick Response Guaranteed | Verified Suppliers
